| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 30, 2007
From the Department of Neurology, Faculty of Medicine, Shimane University, Izumo, Japan. * To whom correspondence should be addressed. E-mail: bokura{at}med.shimane-u.ac.jp.
Background and Purpose—Metabolic syndrome (MetS) is a recognized risk factor for stroke, but it is unclear whether MetS is also related to subclinical ischemic lesions. We examined the association of MetS with the prevalence of silent brain infarction, periventricular hyperintensity, and subcortical white matter lesions in healthy adults. Methods—We conducted a cross-sectional study in 1151 Japanese healthy subjects. Three types of silent lesions were assessed by MRI scans. MetS was diagnosed using the criteria by the National Cholesterol Education Adult Treatment Panel III. Results—After adjusting for age and other factors, MetS was significantly associated with silent brain infarction, periventricular hyperintensity and subcortical white matter lesions. Among the MetS components, elevated blood pressure was commonly associated with all types of lesions. Dyslipidemia and elevated fasting glucose levels were associated with subcortical white matter lesions and periventricular hyperintensities, respectively. Positive trends were observed between the number of MetS components and prevalence of silent lesions. Conclusions—MetS is associated with the prevalence of silent lesions independent of other risk factors. The clustering of MetS components tends to increase the prevalence of silent lesions.
Accepted on November 7, 2007
Metabolic Syndrome Is Associated With Silent Ischemic Brain Lesions
Hirokazu Bokura MD*;
This article has been cited by other articles:
![]() |
T. Liu-Ambrose, L. A. Katarynych, M. C. Ashe, L. S. Nagamatsu, and C. L. Hsu Dual-Task Gait Performance Among Community-Dwelling Senior Women: The Role of Balance Confidence and Executive Functions J Gerontol A Biol Sci Med Sci, September 1, 2009; 64A(9): 975 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Segura, M. A. Jurado, N. Freixenet, C. Falcon, C. Junque, and A. Arboix Microstructural white matter changes in metabolic syndrome: A diffusion tensor imaging study Neurology, August 11, 2009; 73(6): 438 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Putaala, M. Kurkinen, V. Tarvos, O. Salonen, M. Kaste, and T. Tatlisumak Silent brain infarcts and leukoaraiosis in young adults with first-ever ischemic stroke Neurology, May 26, 2009; 72(21): 1823 - 1829. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Thompson and A. M. Hakim Living Beyond Our Physiological Means: Small Vessel Disease of the Brain Is an Expression of a Systemic Failure in Arteriolar Function: A Unifying Hypothesis Stroke, May 1, 2009; 40(5): e322 - e330. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Park and N. Yasuda Association Between Metabolic Syndrome and Minimal Leukoaraiosis Stroke, January 1, 2009; 40(1): e5 - e5. [Full Text] [PDF] |
||||
![]() |
H. Bokura and S. Yamaguchi Response to Letter by Park and Yasuda Stroke, January 1, 2009; 40(1): e6 - e6. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |